Lecanemab was developed by drugmakers Eisai of Japan and Biogen of the United States.
JAPAN / Science & Health
Nov 15, 2024
European agency switches to recommending new Alzheimer's drug
The committee judged that the efficacy of lecanemab outweighs the risk for some patients.
This September, six years after planting, researchers successfully cultivated 12 black truffles totaling 200 grams.
JAPAN / Science & Health
Nov 14, 2024
Japan researchers achieve second success in artificial black truffle cultivation
While black truffles do grow naturally in Japan, cultivation methods are still underdeveloped, prompting ongoing research.
For patients using donanemab, it will cost them about ¥3.08 million per year. But national insurance coverage will have the government shoulder most of the cost.
JAPAN / Science & Health
Nov 13, 2024
Japan OKs insurance coverage of Alzheimer's drug donanemab
Donanemab became the second Alzheimer's drug that targets causative deposited plaque in the brain to win the coverage after lecanemab.
Last year, cashews were responsible for 279 of 6,033 allergy cases, or 4.6%, making them the seventh most common allergenic food.
JAPAN / Science & Health
Nov 11, 2024
Japan weighs mandatory allergen labeling for cashew nuts
Cashews nuts caused 37 cases of severe anaphylactic shock last year, making them the fifth most common trigger.
National Cancer Center Hospital building in Tokyo's Chuo Ward
JAPAN / Science & Health
Nov 9, 2024
Right-sided colon gets rid of cancer, Japanese researchers find
It has been known that colorectal cancer often occurs in the left-sided colorectum while the small intestine and the right colon are almost cancer-free.
The anterior cruciate ligament can be damaged when people play sports such as soccer and basketball, and does not heal on its own, requiring reconstructive surgery.
JAPAN / Science & Health
Nov 7, 2024
Clinical trial to use cow tendons for ligament reconstruction
The number of patients who undergo anterior cruciate ligament surgery in Japan is about 19,000 annually, including many professional soccer players and sumo wrestlers.
The National Cancer Center Hospital in Tokyo's Chuo Ward. A study by researchers at the hospital aims to determine whether restoring a healthy intestinal environment can enhance the effectiveness of immunotherapy drugs used in cancer treatment.
JAPAN / Science & Health
Nov 6, 2024
Japan explores intestinal flora transplants for cancer treatment
A study aims to determine whether restoring a healthy intestinal environment can make drugs used in the treatment of esophageal and stomach cancers more effective.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?